COATING: The first randomized controlled trial evaluating a coated flow diverter

Frédéric Clarençon and Laurent Pierot discuss the results of COATING, the first randomized controlled trial evaluating a surface coating designed to optimize aneurysm treatment with a new generation of flow diverters. One-month results showed no increase in ischemic events or thromboembolic complications in the coated flow diverter group treated with single antiplatelet therapy, demonstrating that it is as safe as using a bare flow diverter with dual antiplatelet therapy. Longer-term evaluation is still needed, and one-year data awaited.

^{Coating to Optimize Aneurysm Treatment in the New Flow Diverter Generation study - The first randomized controlled trial evaluating a coated flow diverter
Full study available here:  https://jnis.bmj.com/content/15/7/684}